Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: A prospective cohort study

Autoimmunity

Volumn 46, Issue 8, 2013, Pages 531-536

  Zou, Yan Feng ^a   Xu, Jian Hua ^a   Wang, Fen ^a   Liu, Shuang ^a   Tao, Jin Hui ^a   Cai, Jing ^a   Lian, Li ^a   Xiao, Hui ^a   Chen, Pei Ling ^a   Tian, Guo ^a   Wu, Min ^a   Wang, De Guang ^a   Liu, Sheng Xiu ^a   Liang, Chun Mei ^a   Pan, Fa Ming ^a   Su, Hong ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Efficacy; Genetic polymorphisms; Glucocorticoid receptor; Glucocorticoids; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROXYCHLOROQUINE; PREDNISONE;

ADULT; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARMACOGENETICS; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

ADULT; ALLELES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, GLUCOCORTICOID; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887468698     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.830714     Document Type: Article

References (30)

1. Borchers, A. T., S. M. Naguwa, Y. Shoenfeld, and M. E. Gershwin. 2010. The geoepidemiology of systemic lupus erythematosus. Autoimmun. Rev. 9: A277-A287
2. Pons-Estel, G. J., G. S. Alarcón, L. Scofield, et al. 2010. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin. Arthritis Rheum. 39: 257-268
3. Trager, J., and M. M. Ward. 2001. Mortality and causes of death in systemic lupus erythematosus. Curr. Opin. Rheumatol. 13: 345-351 (Pubitemid 32929862)
4. Pontillo, A., M. Girardelli, A. J. Kamada, et al. 2012. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity
5. van Rossum, E. F., and E. L. van den Akker. 2011. Glucocorticoid resistance. Endocr. Dev. 20: 127-136
6. Adcock, I. M., Y. Nasuhara, D. A. Stevens, and P. J. Barnes. 1999. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br. J. Pharmacol
7. Pui, C. H., G. V. Dahl, G. Rivera, et al. 1984. The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk. Res. 8: 579-585 (Pubitemid 14051261)
8. Iacobelli, S., P. Marchetti, G. De Rossi, et al. 1987. Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia. Oncology. 44: 13-16 (Pubitemid 17028385)
9. Enćo, I. J., and S. D. Detera-Wadleigh. 1991. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266: 7182-7188 (Pubitemid 21906349)
10. Manenschijn, L., E. L. van den Akker, S. W. Lamberts, and E. F. van Rossum. 2009. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann. N. Y. Acad. Sci. 1179: 179-198
11. Gross, K. L., N. Z. Lu, and J. A. Cidlowski. 2009. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol. Cell Endocrinol. 300: 7-16
12. Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
13. Costedoat-Chalumeau, N., Z. Amoura, J. S. Hulot, et al. 2007. Hydroxychloroquine in systemic lupus erythematosus. Lancet. 369: 1257-1258 (Pubitemid 46552044)
14. Costedoat-Chalumeau, N., G. Leroux, J. C. Piette, and Z. Amoura 2010. Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment Joint Bone Spine. 77: 4-5
15. Carmichael, S. J., B. Charles, and S. E. Tett. 2003. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther. Drug Monit. 25: 671-681 (Pubitemid 37499301)
16. Bateman, A., A. Singh, T. Kral, and S. Solomon. 1989. The immune-hypothalamic-pituitary-adrenal axis. Endocr. Rev
17. Jiang, T., S. Liu, M. Tan, et al. 2001. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clin. Chim. Acta 313: 113-117 (Pubitemid 33016699)
18. Oakley, R. H., M. Sar, and J. A. Cidlowski. 1996. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271: 9550-9559
19. Reichardt, H. M., and G. Schütz. 1998. Glucocorticoid signalling-multiple variations of a common theme. Mol. Cell Endocrinol. 146: 1-6 (Pubitemid 29003274)
20. Pujols, L., A. Xaubet, J. Raḿrez, et al. 2004. Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax. 59: 687-693 (Pubitemid 39061533)
21. Bamberger, C. M., A. M. Bamberger, M. de Castro, and G. P. Chrousos. 1995. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95: 2435-2441
22. Schaaf, M. J., and J. A. Cidlowski. 2003. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Mol. Cell Biol. 23: 1922-1934 (Pubitemid 36278806)
23. Stahn, C., M. Löwenberg, D. W. Hommes, and F. Buttgereit 2007. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell Endocrinol. 275: 71-78 (Pubitemid 47259281)
24. Ehrchen, J., L. Steinmüller, K. Barczyk, et al. 2007. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood. 109: 1265-1274 (Pubitemid 46220679)
25. Gehring, U., K. Mugele, and J. Ulrich. 1984. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol. Cell Endocrinol. 36: 107-113 (Pubitemid 14122925)
26. Vanderbilt, J. N., R. Miesfeld, B. A. Maler, and K. R. Yamamoto 1987. Intracellular receptor concentration limits glucocorticoiddependent enhancer activity. Mol. Endocrinol. 1: 68-74
27. Federico, M. H., V. R. Martins, D. H. Pozzi, et al. 1986. Glucocorticoid receptors in acute leukemia. Braz. J. Med. Biol. Res. 19: 167-172
28. Sakurai, M., H. Kamiya, K. Kawai, et al. 1986. Predictable risk factors in children with acute lymphoblastic leukemia. Med. Pediatr. Oncol. 14: 140-143 (Pubitemid 16054578)
29. Niu, N., V. Manickam, K. R. Kalari, et al. 2009. Human glucocorticoid receptor alpha gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics. J. Clin. Endocrinol. Metab. 94: 3072-3084
30. van Rossum, E. F., J. W. Koper, N. A. Huizenga, et al. 2002. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes. 51: 3128-3134